Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.
about
Vitamin D supplementation for prevention of mortality in adultsUpdate in vitamin D and multiple sclerosisClinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomesVitamin d supplementation for the treatment of acute childhood pneumonia: a systematic reviewHigher predicted vitamin D status is associated with reduced risk of Crohn's disease.Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.The influence of nutritional factors on the prognosis of multiple sclerosis.Prevention and treatment of MS: studying the effects of vitamin D.The conundrum of iron in multiple sclerosis--time for an individualised approach.Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisSafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial.Vitamin D in multiple sclerosis: implications for assessment and treatment.Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology.Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials.Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.Vitamin D modulation of innate immune responses to respiratory viral infections.Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial.Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.Response to comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'.In vitro effect of human serum and fetal calf serum on CD4+ T cells proliferation in response to myelin oligodendrocyte glycoprotein (MOG) in correlation with RBP/TTR ratio in multiple sclerotic patients.Physiological serum 25-hydroxyvitamin D concentrations are associated with improved thyroid function-observations from a community-based program.Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.Role of vitamin D in multiple sclerosis: implications for disease management
P2860
Q24201160-31A61117-B6AD-4B8A-9FA8-916568C27B7CQ26780466-B1F3B925-1E1F-4848-AA9F-7CA8D173D410Q26824192-F0E35EB9-899A-4A05-A261-FB50C994A611Q26828611-8A25E87E-39D7-4EEB-B91C-47119471600FQ30514840-BFC860F0-6F89-49FF-8391-4D1ACBC930DAQ34356485-58D94DC5-EBC0-4B2D-AB0E-1478E9E6F346Q34550631-179DF4ED-ED34-4302-9E9B-A9D4540246DDQ34643392-8EE89440-0E61-4B49-89F8-632BEB6B2C8DQ35956133-7D560530-6A83-4F32-8332-901D9BA07374Q36110218-52FB6969-CDF3-4080-8280-B1B0D616A3A1Q36396585-3A7BFEE7-95E6-4021-848B-69D2EAE3A9C7Q36638670-FCB4B3B7-17F7-437C-A07C-3A54B00380EBQ36645164-96904236-14D9-4929-984D-1FEE492F13D1Q36751056-EEDBA37C-631B-426E-ACA5-3738AE02D50EQ36935388-D11D1B3C-4DE4-41F8-AE40-08AB3258D5A6Q38049627-56399AA8-37F7-414A-BD01-77675FA2E9FCQ38194076-79EEEE89-B493-46B9-8297-8B8F4D589CB3Q38387302-78DCBB65-B442-47D8-9320-D72754099671Q38574475-B36D98C6-58FF-435D-8B24-ABE428E243DBQ38663577-B52F5EBD-2713-482E-BA38-ABD2C9C70DAAQ38934985-20346031-7212-4C73-BA58-44B0FFFD1F06Q38974833-2E2F245D-C855-4E77-94D3-E9B6554C4751Q41715906-CDA685A5-3180-4E63-B872-E42AAA187BC8Q42364107-8BBA0213-1B87-4C3A-BB40-D47E43D225A3Q44582650-FC717F6D-5C24-4C6D-9B75-AAF6245C2DDAQ44851080-E11B817B-0B75-4C78-AD87-F0F847F9A759Q47140852-21CB2129-0562-4903-83B5-C4F9E5AD2F9CQ51415619-60F718F3-5F9A-4A51-BF6F-1122E9988657Q58389952-C2552BA7-B8C3-4587-B8B3-B634E9844090
P2860
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@ast
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@en
type
label
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@ast
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@en
prefLabel
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@ast
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@en
P2093
P2860
P356
P1476
Cholecalciferol plus calcium s ...... ients with multiple sclerosis.
@en
P2093
Amit Bar-Or
Cheryl D'Souza
Donald Gagne
Hans-Michael Dosch
Jodie M Burton
Melanie Ursell
Paul O'Connor
Reinhold Vieth
Roy Cheung
Samantha Kimball
P2860
P304
P356
10.1210/JC.2011-0325
P407
P577
2011-06-22T00:00:00Z